Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP112393.RATQn8jISkYND20DerMD79dO0k-ZMuwnIQi2EIRUGVgCY130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112393.RATQn8jISkYND20DerMD79dO0k-ZMuwnIQi2EIRUGVgCY130_provenance.
• NP51022.RAjXIyGfJdQXlErQPuP4WCJPQMwJuanlBOcH9BGJrSa7M130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP51022.RAjXIyGfJdQXlErQPuP4WCJPQMwJuanlBOcH9BGJrSa7M130_provenance.
• NP90809.RAJzOtunoS8-nntxvxwB3Wv3paEf-2gv_KDoP9vO6r8vY130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP90809.RAJzOtunoS8-nntxvxwB3Wv3paEf-2gv_KDoP9vO6r8vY130_provenance.
• NP153753.RAtnIofPkxvprbEMVXk2JriL-R3M2mE4TbF-T1CVCfIyA130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP153753.RAtnIofPkxvprbEMVXk2JriL-R3M2mE4TbF-T1CVCfIyA130_provenance.
• NP153755.RAvjAdpbWHST2ptYmUf1_wulxTA3CuE8nfFlqFqOXyX80130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP153755.RAvjAdpbWHST2ptYmUf1_wulxTA3CuE8nfFlqFqOXyX80130_provenance.
• NP153758.RApXLxQ3BqD31I41C9g_u-Ga7G0szH2rCcoRcyPHYWAsE130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP153758.RApXLxQ3BqD31I41C9g_u-Ga7G0szH2rCcoRcyPHYWAsE130_provenance.
• NP111608.RA_5dtwbhLWzRlVB2mq_5jCyIiIs9ODOYrFLCpEehnknM130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP111608.RA_5dtwbhLWzRlVB2mq_5jCyIiIs9ODOYrFLCpEehnknM130_provenance.
• NP112070.RA0qCKPDH0S-qhY0D-u19m7nS9ifky00DWhJgyKVKz4as130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP112070.RA0qCKPDH0S-qhY0D-u19m7nS9ifky00DWhJgyKVKz4as130_provenance.
• NP153754.RAxkUqhd7XjGFNLQ-m6MRW5Qs-pr9Wu0JX-vgXaX5BNmo130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP153754.RAxkUqhd7XjGFNLQ-m6MRW5Qs-pr9Wu0JX-vgXaX5BNmo130_provenance.
• NP153756.RA3CyNuVR0en_44Hc27dcOOHPwt8xgksg_THJNIXzgJ54130_assertion description "[We conducted a case-control study, including 209 incident cases with hepatocellular carcinoma (HCC) and two different control groups 275 hospital controls and 381 patients with chronic liver disease (CLD) without HCC, to investigate whether CYP1A1, CYP1A2, CYP2A6, CYP2E1, GSTM1 and NAT2 polymorphisms are related to the risk of HCC with any interaction with cigarette smoking.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP153756.RA3CyNuVR0en_44Hc27dcOOHPwt8xgksg_THJNIXzgJ54130_provenance.